Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN)’s stock price traded down 3.3% during mid-day trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The firm has a 50-day moving average of GBX 3.87 and a two-hundred day moving average of GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insider Activity at Eden Research

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,958.74). 14.02% of the stock is owned by company insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.